The biggest concern about the development of artificial intelligence (AI) in recent years is that it will take human jobs. Well, unfortunately, that is already happening, with a wide range of ...

Voting-rights activists said the changes are a blatant attempt by G.O.P. leaders to make it harder for Black voters and students, who tend to vote for Democrats, to cast ballots this fall. By Nick ...

Type to search articles, cases, and authors. Press ↵ to view all results. Updated on June 3 at 9:40 a.m. The Supreme Court on Tuesday night cleared the way for Alabama to use a congressional map in ...

Homeowners insurance premiums have spiked for many people in recent years, due to factors like inflation and climate change. There are steps that policyholders can take to try to reduce their ...

Burmese pythons are an invasive species in Florida, primarily established in the Everglades and South Florida. These snakes have drastically reduced native mammal populations, including raccoons, ...

Even if you don’t know much about the inner workings of generative AI models, you probably know they need a lot of memory. Hence, it is currently almost impossible to buy a measly stick of RAM without ...

To lower agricultural emissions, policymakers and communities first need to pinpoint the sources—not just by country but crop by crop, field by field. In a study published in Nature Climate Change, ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Need a better way to plan projects? Discover mind map examples that help you visually organize tasks, ideas, and strategies for clearer decision-making. Key takeaways: Mind maps show how visual ...

TikTok, an app that was once just a place for user-generated content, is launching a new setting that lets users choose how much AI-generated content they want to see in their For You feed. The ...

Skye Bioscience’s obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class. The biotech had been evaluating a 200-mg weekly subcutaneous ...